NO325365B1 - Fremgangsmate for alkylering av et glykopeptidantibiotikum samt et kompleks av kobber og nevnte alkylerte glykopeptidantibiotikum. - Google Patents

Fremgangsmate for alkylering av et glykopeptidantibiotikum samt et kompleks av kobber og nevnte alkylerte glykopeptidantibiotikum. Download PDF

Info

Publication number
NO325365B1
NO325365B1 NO19992415A NO992415A NO325365B1 NO 325365 B1 NO325365 B1 NO 325365B1 NO 19992415 A NO19992415 A NO 19992415A NO 992415 A NO992415 A NO 992415A NO 325365 B1 NO325365 B1 NO 325365B1
Authority
NO
Norway
Prior art keywords
glycopeptide antibiotic
copper
complex
mmol
alkyl
Prior art date
Application number
NO19992415A
Other languages
English (en)
Norwegian (no)
Other versions
NO992415D0 (no
NO992415L (no
Inventor
Richard Alan Berglund
Nancy Anne Lockwood
Howard Eugene Magadanz
Hua Zheng
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO992415D0 publication Critical patent/NO992415D0/no
Publication of NO992415L publication Critical patent/NO992415L/no
Publication of NO325365B1 publication Critical patent/NO325365B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19992415A 1996-11-21 1999-05-20 Fremgangsmate for alkylering av et glykopeptidantibiotikum samt et kompleks av kobber og nevnte alkylerte glykopeptidantibiotikum. NO325365B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3159696P 1996-11-21 1996-11-21
PCT/US1997/021238 WO1998022121A1 (en) 1996-11-21 1997-11-20 Reductive alkylation of glycopeptide antibiotics

Publications (3)

Publication Number Publication Date
NO992415D0 NO992415D0 (no) 1999-05-20
NO992415L NO992415L (no) 1999-05-20
NO325365B1 true NO325365B1 (no) 2008-04-14

Family

ID=21860369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992415A NO325365B1 (no) 1996-11-21 1999-05-20 Fremgangsmate for alkylering av et glykopeptidantibiotikum samt et kompleks av kobber og nevnte alkylerte glykopeptidantibiotikum.

Country Status (27)

Country Link
EP (1) EP0845478B1 (cs)
JP (1) JP4308912B2 (cs)
KR (1) KR100514276B1 (cs)
CN (1) CN100463917C (cs)
AR (1) AR010621A1 (cs)
AT (1) ATE286910T1 (cs)
AU (1) AU723941B2 (cs)
BR (1) BR9713523B1 (cs)
CA (1) CA2272240C (cs)
CO (1) CO4650045A1 (cs)
CZ (1) CZ300528B6 (cs)
DE (1) DE69732215T2 (cs)
EA (1) EA002925B1 (cs)
EG (1) EG23855A (cs)
HU (1) HU227641B1 (cs)
ID (1) ID18900A (cs)
IL (1) IL129991A0 (cs)
MY (1) MY117383A (cs)
NO (1) NO325365B1 (cs)
NZ (1) NZ335840A (cs)
PE (1) PE17499A1 (cs)
PL (1) PL190780B1 (cs)
TR (1) TR199901679T2 (cs)
TW (1) TW585868B (cs)
UA (1) UA58526C2 (cs)
WO (1) WO1998022121A1 (cs)
ZA (1) ZA9710428B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60135102D1 (de) * 2000-05-02 2008-09-11 Theravance Inc Verfahren zur reduktiven alkylierung von glykopeptiden
MX388561B (es) 2013-03-15 2025-03-11 Melinta Subsidiary Corp Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.
CA2955256C (en) * 2014-07-17 2023-02-14 The Medicines Company High purity oritavancin and method of producing same
CN106188243B (zh) * 2015-05-05 2020-06-26 博瑞生物医药（苏州）股份有限公司 一种奥利万星的制备方法
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051237A (en) * 1975-08-28 1977-09-27 Bristol-Myers Company Glycopeptide antibiotics bu-2231 a and b and process for producing same
JPS58116497A (ja) * 1981-12-29 1983-07-11 Microbial Chem Res Found アミノプロピルアミノブレオマイシン誘導体及びその製造法
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
NZ236393A (en) * 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
TW457248B (en) * 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
BR9713523A (pt) 2000-03-21
AU723941B2 (en) 2000-09-07
AR010621A1 (es) 2000-06-28
JP4308912B2 (ja) 2009-08-05
PL190780B1 (pl) 2006-01-31
EA002925B1 (ru) 2002-10-31
HUP0000268A2 (hu) 2000-08-28
HUP0000268A3 (en) 2001-04-28
EP0845478B1 (en) 2005-01-12
MY117383A (en) 2004-06-30
CZ179499A3 (cs) 2000-01-12
CO4650045A1 (es) 1998-09-03
EG23855A (en) 2007-11-11
EA199900480A1 (ru) 2000-02-28
EP0845478A1 (en) 1998-06-03
WO1998022121A1 (en) 1998-05-28
CA2272240C (en) 2011-02-08
TW585868B (en) 2004-05-01
KR100514276B1 (ko) 2005-09-13
DE69732215T2 (de) 2006-01-12
HU227641B1 (en) 2011-10-28
IL129991A0 (en) 2000-02-29
ID18900A (id) 1998-05-20
ATE286910T1 (de) 2005-01-15
DE69732215D1 (de) 2005-02-17
NZ335840A (en) 2000-09-29
CN1244802A (zh) 2000-02-16
CA2272240A1 (en) 1998-05-28
UA58526C2 (uk) 2003-08-15
CZ300528B6 (cs) 2009-06-10
HK1011542A1 (en) 1999-07-16
ZA9710428B (en) 1999-05-19
BR9713523B1 (pt) 2010-07-27
NO992415D0 (no) 1999-05-20
TR199901679T2 (xx) 1999-09-21
PE17499A1 (es) 1999-02-19
JP2001504494A (ja) 2001-04-03
KR20000057156A (ko) 2000-09-15
CN100463917C (zh) 2009-02-25
AU5449798A (en) 1998-06-10
NO992415L (no) 1999-05-20

Similar Documents

Publication Publication Date Title
NO314150B1 (no) Amidderivater av antibiotika A-40926, fremgangsmåte for fremstilling av samme, anvendelse av samme for fremstilling av medikament samtfarmasöytisk sammensetning inneholdende samme
NO325365B1 (no) Fremgangsmate for alkylering av et glykopeptidantibiotikum samt et kompleks av kobber og nevnte alkylerte glykopeptidantibiotikum.
US5952466A (en) Reductive alkylation of glycopeptide antibiotics
NZ210470A (en) Isolation of vancomycin;vancomycin diphosphate forms and uses
CN100417661C (zh) 糖肽膦酸酯衍生物的盐酸盐
CA2272261C (en) Reducing agent for reductive alkylation of glycopeptide antibiotics
EP1073447A1 (en) N1-modified glycopeptides
CA2290724C (en) Glycopeptide hexapeptides
Pavlov et al. Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained
US5438117A (en) Hexapeptides deriving from aglucoteicoplanin and a process for preparing them
EP0290922A2 (en) Teicoplanin derivatives
HK1011542B (en) Reductive alkylation of glycopeptide antibiotics
EP0563062B1 (en) Hexapeptides deriving from aglucoteicoplanin and a process for preparing them
HK1011543B (en) Reducing agent for reductive alkylation of glycopeptide antibiotics
HK1093516B (en) Hydrochloride salts of a glycopeptide phosphonate derivative

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees